Completed Brain & Nervous System Genetics & Molecular Biology

The AAGGG repeat expansion in RFC1 associated with late-onset ataxia and sensory neuropathy: from genetic cause to defining the functional mechanism

In plain English

AI plain-English summary

A single genetic typo—a short, repeated DNA sequence in a gene called RFC1—triggers a devastating, late-onset movement disorder that destroys coordination and balance. This condition, known as CANVAS, combines cerebellar ataxia, sensory nerve damage, and loss of the vestibular reflex, yet its cause has remained mysterious for most patients. The researchers discovered that people with two copies of an abnormal AAGGG repeat in RFC1 develop the disease, but the repeat does not simply shut the gene down—it works through an unknown mechanism. This project aims to crack that mechanism. The team will test whether the repeated sequence produces toxic protein fragments, disrupts nearby genes, or scrambles the 3D structure of DNA inside nerve cells. They will use patient-derived cells, fruit flies, and lab experiments to trace exactly how the repeat kills neurons. If successful, this work could reveal a new class of neurological disease—one driven by intronic repeat expansions that act through unexpected pathways. That knowledge could eventually lead to diagnostic tests or therapies for late-onset ataxia, a condition that currently has no cure and often goes undiagnosed.

View original technical description
Late-onset ataxia is a common reason for neurological consultation, but its cause often remains idiopathic. Ataxia primarily results from cerebellar dysfunction but can also be caused by disorders affecting the large-fibre sensory neurons (sensory neuronopathy) or the vestibular system. When in combination, this more severe late onset ataxia is termed cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS). We identified a biallelic intronic AAGGG repeat expansion in the replication factor C subunit 1 (RFC1) as a common cause of CANVAS and late-onset ataxia. The AAGGG repeat expansion does not lead to overt loss of function of RFC1, which is unexpected given the recessive pattern of inheritance of the disease and suggests that novel disease-causing mechanisms could be involved. The main objective of this project is to investigate the molecular mechanisms underlying neurodegeneration in the presence of biallelic AAGGG expansions in RFC1. We will use a combined approach by taking advantage of in vitro experiments, Drosophila model as well as patients'-derived cell lines and tissues in order to test the presence of a dose-dependent gain-of-function of toxic pentapeptide repeat proteins encoded by the transcribed intronic repeated sequence and/or unconventional loss-of-function of tissue specific RFC1 isoforms, non-coding transcripts, neighboring and distant genes and/or reorganization 3D chromatin structure.

View the original record at the funder ↗

Researchers

Andrea Cortese (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

The AAGGG Repeat Expansion in the RFC1 gene: Investigating the functional consequences
Genetic identification and functional characterisation of novel genes implicated in cerebellar ataxia
Genomic observation and perturbation: genetic modifiers to untangle disease mechanisms of RFC1 repeat expansion
C9orf72-mediated neurodegeneration: mechanisms and therapeutics
Investigating the role of overactive mGluR1 signalling in cerebellar development and disease

Original classification

Fellowship

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.